Co-Authors
This is a "connection" page, showing publications co-authored by Philip Robinson and Marc Feldmann.
Connection Strength
1.818
-
The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19. Med (N Y). 2020 Dec 18; 1(1):90-102.
Score: 0.917
-
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment. Lancet Rheumatol. 2020 Nov; 2(11):e653-e655.
Score: 0.901
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.